# Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery

> **NCT02891070** · PHASE3 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 224 (actual)

## Conditions studied

- Cerebrospinal Fluid Leak

## Interventions

- **DRUG:** FS VH S/D 500 s-apr
- **DEVICE:** DuraSeal Dural Sealant

## Key facts

- **NCT ID:** NCT02891070
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-11
- **Primary completion:** 2018-08-22
- **Final completion:** 2018-08-22
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02891070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02891070, "Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02891070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*